Immunome Inc
NASDAQ:IMNM
Income Statement
Earnings Waterfall
Immunome Inc
Revenue
|
14m
USD
|
Operating Expenses
|
-42.7m
USD
|
Operating Income
|
-28.7m
USD
|
Other Expenses
|
-78.1m
USD
|
Net Income
|
-106.8m
USD
|
Income Statement
Immunome Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
7
+181%
|
10
+54%
|
14
+38%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(12)
|
(11)
|
(17)
|
(21)
|
(25)
|
(33)
|
(36)
|
(37)
|
(37)
|
(32)
|
(33)
|
(33)
|
(43)
|
|
Selling, General & Administrative |
(5)
|
(5)
|
(8)
|
(10)
|
(11)
|
(13)
|
(13)
|
(14)
|
(14)
|
(13)
|
(14)
|
(15)
|
(20)
|
|
Research & Development |
(7)
|
(5)
|
(9)
|
(12)
|
(14)
|
(20)
|
(23)
|
(23)
|
(23)
|
(19)
|
(19)
|
(18)
|
(23)
|
|
Operating Income |
(12)
N/A
|
(11)
+12%
|
(17)
-53%
|
(21)
-30%
|
(25)
-18%
|
(33)
-31%
|
(36)
-10%
|
(37)
-2%
|
(37)
+0%
|
(30)
+19%
|
(27)
+11%
|
(23)
+15%
|
(29)
-27%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(6)
|
(6)
|
(6)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
3
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(81)
|
|
Total Other Income |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(18)
N/A
|
(16)
+8%
|
(22)
-32%
|
(21)
+3%
|
(25)
-18%
|
(32)
-31%
|
(36)
-11%
|
(37)
-2%
|
(37)
+0%
|
(30)
+20%
|
(26)
+11%
|
(22)
+16%
|
(107)
-386%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(18)
|
(16)
|
(22)
|
(21)
|
(25)
|
(32)
|
(36)
|
(37)
|
(37)
|
(30)
|
(26)
|
(22)
|
(107)
|
|
Net Income (Common) |
(18)
N/A
|
(16)
+8%
|
(22)
-32%
|
(21)
+3%
|
(25)
-18%
|
(32)
-31%
|
(36)
-11%
|
(38)
-4%
|
(38)
+0%
|
(30)
+20%
|
(27)
+11%
|
(22)
+18%
|
(107)
-386%
|
|
EPS (Diluted) |
-1.67
N/A
|
-1.54
+8%
|
-1.88
-22%
|
-1.75
+7%
|
-2.14
-22%
|
-2.67
-25%
|
-2.97
-11%
|
-3.1
-4%
|
-3.09
+0%
|
-2.48
+20%
|
-2.2
+11%
|
-1.81
+18%
|
-5.38
-197%
|